期刊
RSC ADVANCES
卷 10, 期 43, 页码 25517-25528出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/d0ra04970k
关键词
-
资金
- Ministry of Higher Education, Malaysia under Fundamental Research Grant Scheme [FRGS/1/2015/SG01/MUSM/03/1]
- School of Pharmacy, Monash University Malaysia
- Sunway University Sdn Bhd [STR-RCTR-RCCM-001-2019]
New 6,N-2-diaryl-1,3,5-triazine-2,4-diamines were designed using the 3D-QSAR model developed earlier. These compounds were prepared and their antiproliferative activity was evaluated against three breast cancer cell lines (MDA-MB231, SKBR-3 and MCF-7) and non-cancerous MCF-10A epithelial breast cells. The synthesized compounds demonstrated selective antiproliferative activity against triple negative MDA-MB231 breast cancer cells. The most active compound in the series inhibited MDA-MB231 breast cancer cell growth with a GI(50)value of 1 nM. None of the tested compounds significantly affected the growth of the normal breast cells. The time-dependent cytotoxic effect, observed when cytotoxicity was assessed at different time intervals after the treatment, and morphological features, observed in the fluorescence microscopy and live cell imaging experiments, suggested apoptosis as the main pathway for the antiproliferative activity of these compounds against MDA-MB231 cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据